Michaël Baumann

25.6k total citations · 4 hit papers
530 papers, 15.4k citations indexed

About

Michaël Baumann is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Michaël Baumann has authored 530 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Pulmonary and Respiratory Medicine, 150 papers in Radiology, Nuclear Medicine and Imaging and 147 papers in Oncology. Recurrent topics in Michaël Baumann's work include Advanced Radiotherapy Techniques (81 papers), Lung Cancer Treatments and Mutations (67 papers) and Radiation Therapy and Dosimetry (59 papers). Michaël Baumann is often cited by papers focused on Advanced Radiotherapy Techniques (81 papers), Lung Cancer Treatments and Mutations (67 papers) and Radiation Therapy and Dosimetry (59 papers). Michaël Baumann collaborates with scholars based in Germany, United States and Netherlands. Michaël Baumann's co-authors include Mechthild Krause, Daniel Zips, Rićhard P. Hill, Ala Yaromina, Howard D. Thames, Anna Dubrovska, Wolfgang Eicheler, Christian Richter, Mahmoud Toulany and H. Peter Rodemann and has published in prestigious journals such as Nature, Cell and JAMA.

In The Last Decade

Michaël Baumann

512 papers receiving 15.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expanding global access to radiotherapy

2015 683 citations Michaël Baumann et al. profile →
Exploring the role of cancer stem cells in radioresistance

2008 661 citations Michaël Baumann, Mechthild Krause et al. profile →
Radiation oncology in the era of precision medicine

2016 567 citations Michaël Baumann, Mechthild Krause et al. profile →
First clinical application of a prompt gamma based in vivo proton range verification system

2016 232 citations Christian Richter, Michaël Baumann et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Michaël Baumann

Since Specialization

Citations

This map shows the geographic impact of Michaël Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Baumann more than expected).

Fields of papers citing papers by Michaël Baumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Baumann. The network helps show where Michaël Baumann may publish in the future.

Co-authorship network of co-authors of Michaël Baumann

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Baumann. A scholar is included among the top collaborators of Michaël Baumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Baumann. Michaël Baumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	When a Prophecy Comes True: Ethyleneoxynitazene as a 'Prophetic' Member of the Emerging Class of 2-Benzylbenzimidazole 'Nitazene' Synthetic Opioids 2024 ·Drug and Alcohol Dependence ·Marthe M. Vandeputte, Grant C. Glatfelter, Donna Walther, (unknown), Donna M. Iula, Michaël Baumann, Christophe P. Stove	1
2	Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P) 2022 ·Cancers ·Tobias Hölscher, Michaël Baumann, Jörg Kotzerke, Klaus Zöphel, Frank Paulsen, Arndt‐Christian Müller, Daniel Zips, Christian Thomas, Manfred P. Wirth, Esther G.C. Troost, Mechthild Krause, Steffen Löck, Fabian Lohaus	4
3	How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment 2021 ·PharmacoEconomics ·Michael Schlander, K. Hernández-Villafuerte, Chih‐Yuan Cheng, Jorge Mestre-Ferrándiz, Michaël Baumann	176
4	Radiation Oncology – Towards a mission‐oriented approach to cancer 2020 ·Molecular Oncology ·Michaël Baumann, Carol Bacchus	2
5	Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma 2020 ·Clinical Cancer Research ·Annekatrin Seidlitz, Bettina Beuthien‐Baumann, Steffen Löck, (unknown), Ivan Platzek, Klaus Zöphel, Annett Linge, Jörg Kotzerke, Jan Petr, Jörg van den Hoff, Jörg Steinbach, Dietmar Krex, (unknown), (unknown), Michaël Baumann, Mechthild Krause	14
6	Cancer stem cells in radiation response: current views and future perspectives in radiation oncology 2019 ·International Journal of Radiation Biology ·Claudia Peitzsch, Ina Kurth, (unknown), Anna Dubrovska, Michaël Baumann	26
7	Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens 2019 ·Radiotherapy and Oncology ·(unknown), Steffen Löck, Volker Gudziol, Sandra Hering, Rebecca Bütof, (unknown), Michaël Baumann, Mechthild Krause, Cläre von Neubeck	14
8	Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining 2018 ·Clinical Cancer Research ·Qi Liu, Lin Ma, Trevor J. Jones, Luís Palomero, Miguel Ángel Pujana, (unknown), Patrick K. Ha, John P. Murnane, Isabel Cuartas, Joan Seoane, Michaël Baumann, Annett Linge, Mary Helen Barcellos‐Hoff	72
9	Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway 2017 ·Cancer Research ·(unknown), Jing Han, Lynnette Marcar, Joshua C. Black, Qi Liu, Xiangyong Li, Kshithija Nagulapalli, Lecia V. Sequist, Raymond H. Mak, Cyril H. Benes, Theodore S. Hong, Kristin Gurtner, Mechthild Krause, Michaël Baumann, Jing X. Kang, Johnathan R. Whetstine, Henning Willers	77
10	Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials 2016 ·Clinical Cancer Research ·C. Norman Coleman, Geoff S. Higgins, J. Martin Brown, Michaël Baumann, David G. Kirsch, Henning Willers, Pataje G.S. Prasanna, Mark W. Dewhirst, Eric J. Bernhard, Mansoor M. Ahmed	59
11	An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells 2016 ·Cancer Research ·Claudia Peitzsch, Monica Cojoc, (unknown), Ina Kurth, Katrin Mäbert, Franziska Trautmann, Barbara Klink, Evelin Schröck, Manfred P. Wirth, Mechthild Krause, (unknown), Г. Д. Телегеев, (unknown), Marieta Toma, Michael H. Muders, Gustavo Baretton, Fiona M. Frame, Norman J. Maitland, Michaël Baumann, Anna Dubrovska	57
12	Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells 2015 ·Cancer Research ·Monica Cojoc, Claudia Peitzsch, Ina Kurth, Franziska Trautmann, Leoni A. Kunz‐Schughart, Г. Д. Телегеев, (unknown), John R. Walker, Karl Simin, Stephen Lyle, Susanne Fuessel, Kati Erdmann, Manfred P. Wirth, Mechthild Krause, Michaël Baumann, Anna Dubrovska	187
13	Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure 2015 ·Acta Oncologica ·Sebastian Zschaeck, Robert Haase, Nasreddin Abolmaali, Rosalind Perrin, Kristin Stützer, Steffen Appold, Jörg Steinbach, Jörg Kotzerke, Daniel Zips, Christian Richter, Volker Gudziol, Mechthild Krause, Klaus Zöphel, Michaël Baumann	48
14	Mitteilungen der Fachgesellschaften 2014 ·Strahlentherapie und Onkologie ·Rolf Sauer, Michaël Baumann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
15	EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation 2014 ·Cancer Research ·Meng Wang, (unknown), (unknown), Patricia Greninger, Anurag Singh, Yunfeng Pan, Dipanjan Chowdhury, Mechthild Krause, Michaël Baumann, Cyril H. Benes, Jason A. Efstathiou, Jeff Settleman, Henning Willers	55
16	EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks 2011 ·Cancer Research ·Meng Wang, (unknown), David M. Sander, Liliana Gheorghiu, Akash Nanda, Cyril H. Benes, Malte Kriegs, Mechthild Krause, Ekkehard Dikomey, Michaël Baumann, Jochen Dahm‐Daphi, Jeffrey Settleman, Henning Willers	96
17	Prosper: image and robot-guided prostate brachytherapy 2011 ·arXiv (Cornell University) ·Michaël Baumann, M. Bolla, (unknown), Jean‐Luc Descotes, Jean-Yves Giraud, Nikolai Hungr, (unknown), Jean‐Alexandre Long, Sébastien Martin, Jocelyne Troccaz	1
18	Zwei oder vier Stunden [18F]FMISO-PET in Kopf-Hals-Karzinomen: 2011 ·Nuklearmedizin - NuclearMedicine ·Nasreddin Abolmaali, Robert Haase, A. Koch, Daniel Zips, Jörg Steinbach, Michaël Baumann, J. Kotzerke, Klaus Zöphel	32
19	[Tumor growth of non-small-cell bronchial carcinoma during the waiting time for curative radiotherapy]. 2001 ·PubMed ·Christina Bjørk Petersen, Michaël Baumann	1
20	[Problems of radiotherapy in Germany after the recent events in Hamburg]. 1994 ·PubMed ·Hans‐Peter Beck‐Bornholdt, Michaël Baumann, Torsten Herrmann, M. Molls, R. Sauer, K.R. Trott	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact